Find the content you are looking for on Diabetech by searching the desired device, company, or topic.
Feb 12, 2026
•
2 min read
MannKind’s INHALE‐1ST trial is testing an inhaled insulin, as a needle‐free option for children with type 1 diabetes with an expected FDA decision by May 29, 2026.
Feb 11, 2026
The company has began production of validation lots for its tubeless insulin pump aimed at “almost‐pumpers,” with plans for an early 2026 commercial debut still on track.
Feb 10, 2026
Early clinical data shows the London startup’s tiny, minimally invasive, sensor matches commercial CGM accuracy.
Feb 9, 2026
3 min read
Dexcom's G7 Trends tab offers users more diabetes insights, showcasing time in range, sensor usage, and key metrics, with more insights expected in the future.
Portal Diabetes is developing a fully closed-loop implantable pump that delivers insulin into the intraperitoneal cavity—achieving 4–5× faster insulin action.
Feb 6, 2026
4 min read
Insulet's highly anticipated data platform, Omnipod Discover, is available to healthcare providers and Omnipod users across the Middle East.
